Update shared on 09 Dec 2025
Fair value Decreased 1.33%Analysts have modestly trimmed their price target on Afya, reducing fair value by approximately 1 percent to about $18.53. This reflects expectations for slower revenue growth and slightly lower profit margins, partly offset by a higher assumed future P/E multiple.
What's in the News
- Afya reaffirmed its 2025 earnings guidance, targeting revenue between BRL 3,670 million and BRL 3,770 million, signaling confidence in its medium term growth outlook (company guidance).
- The company agreed to repurchase all 150,000 Series A perpetual convertible preferred shares from SoftBank affiliate SBLA Holdco LLC for BRL 831.6 million, with closing expected on November 3, 2025, and plans to cancel these shares after completion (preferred stock buyback).
- Afya completed a share buyback tranche between August 13, 2025 and September 30, 2025, repurchasing 136,507 shares, or about 0.15 percent of outstanding shares, for BRL 11.13 million under its previously announced program (buyback update).
- The company is preparing for an analyst and investor day focused on its strategic evolution, business priorities and long term value creation framework (analyst and investor event).
Valuation Changes
- Fair value estimate edged down slightly from $18.78 to $18.53 per share, a reduction of roughly 1 percent.
- Discount rate decreased marginally from 10.99 percent to about 10.92 percent, reflecting a modestly lower perceived risk profile.
- Revenue growth was reduced meaningfully from about 7.97 percent to 5.54 percent, indicating a more cautious outlook on top line expansion.
- Net profit margin was lowered from approximately 25.62 percent to 22.84 percent, implying expectations for somewhat weaker profitability.
- Future P/E increased from 11.37x to about 12.95x, signaling a slightly higher assumed valuation multiple despite softer fundamentals.
Have other thoughts on Afya?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
